| # | Drug | Count |
|---|---|---|
| 0 | TENOFOVIR DISOPROXIL FUMARATE | 17 |
| 1 | TENOFOVIR ALAFENAMIDE | 10 |
| 2 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 9 |
| 3 | CYCLOPHOSPHAMIDE | 8 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 8 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 8 |
| 6 | LAMIVUDINE | 8 |
| 7 | RITUXIMAB | 8 |
| 8 | LAMIVUDINE ORAL | 7 |
| 9 | PREDNISONE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BULEVIRTIDE | 6 | 0.0625 |
| 1 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 9 | 0.0010 |
| 2 | ADEFOVIR DIPIVOXIL | 1 | 0.0008 |
| 3 | ENTECAVIR | 6 | 0.0005 |
| 4 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| 5 | CYCLOSERINE | 1 | 0.0004 |
| 6 | ABACAVIR SULFATE | 4 | 0.0004 |
| 7 | DEUCRAVACITINIB | 1 | 0.0003 |
| 8 | LAMIVUDINE | 8 | 0.0003 |
| 9 | ENASIDENIB MESYLATE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 11 | 0.0002 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 13 | 0.0001 |
| 3 | Thiazide-like Diuretic [EPC] | 4 | 0.0001 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 5 | Topoisomerase Inhibitor [EPC] | 6 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 7 | Vitamin D Analog [EPC] | 1 | 0.0001 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 5 | 0.0001 |
| 9 | Intestinal Lipase Inhibitor [EPC] | 1 | 0.0000 |